HOME >> BIOLOGY >> NEWS
Advances in 'micro' RNA exploring process of life

CORVALLIS, Ore. Researchers at Oregon State University have made an important advance in the understanding of "micro-RNA" molecules, which are tiny bits of genetic material that were literally unknown 10 years ago but now represent one of the most exciting new fields of study in biology.

The findings will be reported Friday in the journal Science.

They reveal for the first time a new mechanism by which micro-RNA can stop the function of messenger-RNA by literally cutting it in half, interfering with the normal function of specific messenger RNAs in gene expression.

This "expression" of genes that code for essential proteins is ultimately what controls whether a cell turns into a lung, liver, brain or other cell. Understanding what activates this process or stops it is a key to understanding the biological process of life itself, and forms the foundation for advances in medicine, agriculture and other fields.

On this frontier of biology, experts say, the most intriguing new component is micro-RNA, a minuscule type of regulatory molecule that had seemed insignificant even in the extraordinarily tiny, microscopic world of cell biology.

The first micro-RNA, in fact, was only discovered in 1993 and at the time was thought to be a biological oddity in worms. A couple hundred have since been discovered in both plants and animals. But it has only been in just the past few months that scientists working in this area have come to understand the potentially profound importance of micro-RNA.

"For a long time, people really did not know that these micro-RNAs were even there," said James Carrington, professor and director of the OSU Center for Gene Research and Biotechnology. "They were under the radar, and observations of them were limited by our technology. But as we learn more about these regulatory molecules, we're beginning to understand the scope of their biological importance. In molecular biology, micro-RNAs are clearly one of the top
'"/>

Contact: James Carrington
carrington@orst.edu
541-737-3347
Oregon State University
19-Sep-2002


Page: 1 2 3

Related biology news :

1. Advances in tumor angiogenesis Dendritic cells co-opted to the dark side
2. Advances in equine cloning may aid insight into human diseases
3. Advances in prosthetic, orthopedic, and audiologic diagnostic tools
4. Advances developed to detect bioterrorist agents could find use in protecting food supplies
5. Advances in gene therapy for hemophilia to be addressed at AAAS lecture
6. Clinical Advances towards the simplification if HIV therapy: First once-daily dosing results for the HIV protease inhibitor, Agenerase
7. Advances in animal medicine increase quality of life for older pets
8. Advances in engineering heart tissue reported by MIT scientists, colleagues
9. American Heart Association Announces Top 10 Research Advances For 1998 -- Gene Therapy Among The List
10. Science Announces Top Ten Research Advances Of 1998
11. Duke Scientist Reports Advances In Gene Therapy For Heart Failure

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Advances micro RNA exploring process life

(Date:5/21/2013)... the world,s largest scientific society, invites news media ... September 8-12, 2013, in Indianapolis, Ind. It will ... at area hotels. , With more than 7,100 ... from astronomy to zoology ― the meeting ... rich assortment of spot news and feature possibilities. ...
(Date:5/21/2013)... which alter the way genes function without changing ... in the blood of pregnant women during any ... depression in the weeks after giving birth, and ... , The findings of the small study involving ... journal Molecular Psychiatry . , "Postpartum depression ...
(Date:5/20/2013)... suggests that a compound abundant in the Mediterranean diet ... , By altering a very specific step in gene ... cells that die as scheduled. , One way that ... would cause them to die on a regular cycle ... cells, led by Ohio State University researchers, found that ...
Breaking Biology News(10 mins):Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3
(Date:5/21/2013)... May 21, 2013 According to ... ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the ... and is expected to grow at a CAGR of ... value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
(Date:5/21/2013)... Revolutionary Science, the manufacturer of the ... today that they have expanded their colony counter product ... IntelliCount, InCount and ImpressCount. These affordable colony counters ... in food microbiology and pharmaceutical manufacturing. , The previously ... A bright white enclosure with jet black accents represent ...
(Date:5/21/2013)... MA (PRWEB) May 21, 2013 Possible mold ... And so, according to a report from eagletribune.com posted May ... mold. In case the result is positive, My Cleaning Products ... using harmful chemical ingredients. , It was said in the ... re-infestation in the campus sparked after a first-grade classroom ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
Cached News: